I TP (immune thrombocytopenia) is an autoimmune disorder where the body attacks its own blood platelets. This leads to a ...

A new combination therapy that pairs a radiopharmaceutical (177Lu-DOTATATE) with a DNA-repair blocker (olaparib) has been ...

Results of a randomized, placebo-controlled study demonstrated avatrombopag achieved the primary endpoint of platelet response in heavily pretreated pediatric patients with persistent or chronic ITP.

The "Thrombocytopenia - Global Clinical Trials Review, 2025" has been added to ResearchAndMarkets.com's offering. This extensive report offers key top-line data concerning ongoing Thrombocytopenia ...

WELLESLEY HILLS, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, ...

The Marketing Authorization Application (MAA) for Day One Biopharmaceuticals and Ipsen’s tovorafenib was accepted for review by the European Marketing Authority (EMA) and Takeda initiated its Phase 3 ...

Have you ever felt like your body isn’t quite playing by the rules? Living with Immune Thrombocytopenia (ITP) can sometimes feel like an unpredictable journey, with fluctuating platelet levels and ...

Rilzabrutinib has shown clear evidence of efficacy and safety in patients with persistent immune thrombocytopenia (ITP) who have not responded to previous lines of therapy, according to results ...

What is Thrombosis Thrombocytopenia Syndrome (TTS)? TTS is characterized by blood clots (thrombosis) combined with low levels of platelets (thrombocytopenia), which are necessary for blood clotting.

Thrombocytopenia is the condition when you don’t have enough platelets in your blood. Platelets are small blood cells that clot your blood after you get any cut or scrape that bleeds or a bigger ...

Aspirin can potentially make issues with blood clotting worse. Thrombocytopenia is the medical term for low platelet count. Platelets are a type of blood cell that helps your blood clot.

Hereditary thrombocytopenia, also called inherited thrombocytopenia, is a low platelet count caused by genetic factors, meaning parents carried genes that predisposed a child to the condition.